These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1756915)

  • 1. Impaired expression of glycogen synthase mRNA in skeletal muscle of NIDDM patients.
    Vestergaard H; Bjørbaek C; Andersen PH; Bak JF; Pedersen O
    Diabetes; 1991 Dec; 40(12):1740-5. PubMed ID: 1756915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycogen synthase and phosphofructokinase protein and mRNA levels in skeletal muscle from insulin-resistant patients with non-insulin-dependent diabetes mellitus.
    Vestergaard H; Lund S; Larsen FS; Bjerrum OJ; Pedersen O
    J Clin Invest; 1993 Jun; 91(6):2342-50. PubMed ID: 8514849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
    Vestergaard H
    Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms.
    Henry RR; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Park KS; Nikoulina SE
    J Clin Invest; 1996 Sep; 98(5):1231-6. PubMed ID: 8787686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased concentrations of glycogen synthase protein in skeletal muscle of patients with NIDDM.
    Löfman M; Yki-Järvinen H; Parkkonen M; Lindström J; Koranyi L; Schalin-Jäntti C; Groop L
    Am J Physiol; 1995 Jul; 269(1 Pt 1):E27-32. PubMed ID: 7631777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired activity and gene expression of hexokinase II in muscle from non-insulin-dependent diabetes mellitus patients.
    Vestergaard H; Bjørbaek C; Hansen T; Larsen FS; Granner DK; Pedersen O
    J Clin Invest; 1995 Dec; 96(6):2639-45. PubMed ID: 8675629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants in promoters and coding regions of the muscle glycogen synthase and the insulin-responsive GLUT4 genes in NIDDM.
    Bjørbaek C; Echwald SM; Hubricht P; Vestergaard H; Hansen T; Zierath J; Pedersen O
    Diabetes; 1994 Aug; 43(8):976-83. PubMed ID: 8039605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
    Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
    Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cloning of a human insulin-stimulated protein kinase (ISPK-1) gene and analysis of coding regions and mRNA levels of the ISPK-1 and the protein phosphatase-1 genes in muscle from NIDDM patients.
    Bjørbaek C; Vik TA; Echwald SM; Yang PY; Vestergaard H; Wang JP; Webb GC; Richmond K; Hansen T; Erikson RL
    Diabetes; 1995 Jan; 44(1):90-7. PubMed ID: 7813820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired activation of glycogen synthase in people at increased risk for developing NIDDM.
    Schalin-Jäntti C; Härkonen M; Groop LC
    Diabetes; 1992 May; 41(5):598-604. PubMed ID: 1568529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unchanged gene expression of glycogen synthase in muscle from patients with NIDDM following sulphonylurea-induced improvement of glycaemic control.
    Vestergaard H; Lund S; Bjørbaek C; Pedersen O
    Diabetologia; 1995 Oct; 38(10):1230-8. PubMed ID: 8690177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between polymorphism of the glycogen synthase gene and non-insulin-dependent diabetes mellitus.
    Groop LC; Kankuri M; Schalin-Jäntti C; Ekstrand A; Nikula-Ijäs P; Widén E; Kuismanen E; Eriksson J; Franssila-Kallunki A; Saloranta C
    N Engl J Med; 1993 Jan; 328(1):10-4. PubMed ID: 8416266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequence of the human glycogen-associated regulatory subunit of type 1 protein phosphatase and analysis of its coding region and mRNA level in muscle from patients with NIDDM.
    Chen YH; Hansen L; Chen MX; Bjørbaek C; Vestergaard H; Hansen T; Cohen PT; Pedersen O
    Diabetes; 1994 Oct; 43(10):1234-41. PubMed ID: 7926294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-stimulated muscle glucose clearance in patients with NIDDM. Effects of one-legged physical training.
    Dela F; Larsen JJ; Mikines KJ; Ploug T; Petersen LN; Galbo H
    Diabetes; 1995 Sep; 44(9):1010-20. PubMed ID: 7657022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism of the glycogen synthase gene in hypertensive and normotensive subjects.
    Schalin-Jäntti C; Nikula-Ijäs P; Huang X; Lehto M; Knudsen P; Syvänne M; Lehtovirta MT; Tikkanen T; Tikkanen I; Groop LC
    Hypertension; 1996 Jan; 27(1):67-71. PubMed ID: 8591890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pre- and posttranslational upregulation of muscle-specific glycogen synthase in athletes.
    Vestergaard H; Andersen PH; Lund S; Schmitz O; Junker S; Pedersen O
    Am J Physiol; 1994 Jan; 266(1 Pt 1):E92-101. PubMed ID: 8304448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia.
    Nikoulina SE; Ciaraldi TP; Abrams-Carter L; Mudaliar S; Park KS; Henry RR
    Diabetes; 1997 Jun; 46(6):1017-24. PubMed ID: 9166674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin receptor function and glycogen synthase activity in human skeletal muscle. Physiology and pathophysiology.
    Bak JF
    Dan Med Bull; 1994 Apr; 41(2):179-92. PubMed ID: 8039433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes.
    Nikoulina SE; Ciaraldi TP; Mudaliar S; Mohideen P; Carter L; Henry RR
    Diabetes; 2000 Feb; 49(2):263-71. PubMed ID: 10868943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversibility of the defect in glycogen synthase activity in skeletal muscle from obese patients with NIDDM treated with diet and metformin.
    Damsbo P; Hermann LS; Vaag A; Hother-Nielsen O; Beck-Nielsen H
    Diabetes Care; 1998 Sep; 21(9):1489-94. PubMed ID: 9727896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.